Peroxisome proliferator-activated receptor δ (PPARδ), a novel target site for drug discovery in metabolic syndrome

Medicine and Dentistry

• Peroxisome Proliferator Activated Receptor 66%
• Peroxisome Proliferator Activated Receptor Agonist 41%
• Metabolic Syndrome 33%
• Therapeutic Procedure 33%
• Agonist 16%
• Skeletal Muscle 16%
• Fatty Acid Metabolism 16%
• Adipose Tissue 16%
• Muscle Tissue 16%
• Fatty Acid Oxidation 8%
• Obesity 8%
• Lipid 8%
• Diabetes Mellitus 8%
• Glucose Metabolism 8%
• Ischemic Heart Disease 8%
• Fatty Acid 8%
• Prevalence 8%
• Maturity Onset Diabetes of the Young 8%
• Exercise 8%
• Development 8%
• Hypertriglyceridemia 8%
• Dissipation 8%
• Drug 8%
• Insulin Sensitivity 8%
• Caloric Restriction 8%
• Chemotherapeutic Agent 8%
• Indicator 8%
• Analysis 8%

Biochemistry, Genetics and Molecular Biology

• Peroxisome Proliferator-Activated Receptor 100%
• Receptor Agonists 41%
• Agonist 16%
• Skeletal Muscle 16%
• Beta Oxidation 8%
• Prevalence 8%
• Glucose Metabolism 8%
• Energy 8%
• Development 8%
• Exercise 8%
• Light 8%
• Hypertriglyceridemia 8%
• Insulin Sensitivity 8%
• Lipid Profile 8%
• Fatty Acid 8%